Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: trastuzumab|DRUG: lapatinib ditosylate|OTHER: laboratory biomarker analysis|PROCEDURE: adjuvant therapy|PROCEDURE: neoadjuvant therapy|PROCEDURE: therapeutic conventional surgery
Sponsor: Institute of Cancer Research, United Kingdom
Collaborators: University of Manchester|Manchester University NHS Foundation Trust|Cancer Research UK|Novartis